{ "items": [ "\n\n
\n \n Conference paper\n \n
\n \n\n \n \n \nTalbot DC. et al, (2013), JOURNAL OF CLINICAL ONCOLOGY, 31
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nChurch DN. and Talbot DC., (2013), Curr Oncol Rep, 15
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nO'Brien MER. et al, (2013), European Journal of Cancer, 49, 2815 - 2822
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBriggs SE. et al, (2013), Immunotargets Ther, 2, 31 - 37
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nRamalingam SS. et al, (2012), J Clin Oncol, 30, 3337 - 3344
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nOlsen AL. et al, (2012), Mol Ther Nucleic Acids, 1
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nChurch DN. and Talbot DC., (2012), Curr Oncol Rep, 14, 120 - 128
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKhan OA. et al, (2011), BRITISH JOURNAL OF CANCER, 105, 1252 - 1252
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKhan OA. et al, (2011), British Journal of Cancer, 105
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nEarly Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2011), Lancet, 378, 771 - 784
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCatt S. et al, (2011), Eur J Cancer, 47, 1490 - 1497
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKhan OA. et al, (2011), Br J Cancer, 104, 1822 - 1827
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMedley L. et al, (2011), British Journal of Cancer, 104, 1067 - 1070
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHerrington WG. et al, (2011), Am J Kidney Dis, 57, 300 - 303
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMorel A. et al, (2011), Thorax, 66, 448 - 449
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKhan OA. et al, (2011), British Journal of Cancer
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSaleem A. et al, (2011), Theranostics, 1, 290 - 301
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nEarly Breast Cancer Trialists' Collaborative G., (2011), Lancet, 378, 771 - 784
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nJenkins V. et al, (2011), J Clin Oncol, 29, 61 - 68
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTalbot DC. et al, (2010), Clin Cancer Res, 16, 6150 - 6158
\n \n \n \n\n \n
\n \n \n